A highly specialized portfolio of companies with strong management teams and demonstrated clinical efficacy.
Ardian developed tools for the treatment of hypertension. Medtronic acquired Ardian in January 2011.
Arterys is developing a cloud based medical imaging SaaS analytics platform.
Avinger (NASDAQ: AVGR) has developed an image-guided, catheter-based systems to treat patients with peripheral arterial disease, or PAD.
BioTrace Medical is developing next generation cardiac pacing leads.
Chrono Therapeutics is developing a next generation transdermal drug delivery system.
Cianna Medical, Inc. is using SAVI technologies to transform how care is delivered to patients with early stage breast cancer.
Crux Biomedical developed an improved, retrievable, implantable, vena cava filter to prevent the occurrence of pulmonary embolisms. Volcano Corporation acquired Crux Biomedical in December 2012.
CyberHeart is developing the first non-invasive robotic ablation treatment for cardiac arrhythmias, such as atrial fibrillation or ventricular tachycardia.
Evalve developed devices to enable percutaneous repair of cardiac valves. Abbott Vascular acquired Evalve in October 2009.
EBR Systems is developing ultrasound based wireless stimulation therapies.
Focal Therapeutics is developing innovative tissue marking devices to be used in surgery.
Figure 8 Surgical
Figure 8 Surgical is developing improved sternum closure devices.
Fractyl is developing innovative procedures and devices to address insulin resistance and restore metabolic health.
HeartFlow is developing an innovative technology that uses data from a standard CT scan to create a personalized 3D model of the coronary arteries and analyze the impact that blockages have on blood flow, enabling the determination of FFR in a non-invasive manner.
Hemosphere is developing a device to for long-term subcutaneous AV access for access-challenged hemodialysis patients. Acquired by Cryolife May 2012.
Incline Therapeutics developed a drug-device combination product for the treatment of post-operative pain. The Medicines Company acquired Incline Therapeutics in January 2013.
Intuity Medical is developing POGOTM, the first All-in-OneTM blood glucose monitoring system.
Nanostim is developing miniaturized cardiac rhythm devices. Acquired by St. Jude Medical October 2014
Novare Surgical Systems
Novare was formed to develop innovative devices for minimally invasive surgery, specifically laparoscopic surgery. Vitalitec International, Inc. acquired Novare's ENCLOSE II Anastomosis Assist Device in February 2011. Acquired by Intuitive Surgical.
NovaSom is a medical device manufacturer and diagnostic service provider for home testing for the diagnosis of sleep disordered breathing, including Obstructive Sleep Apnea (OSA).
Orlucent is an early stage company working on a diagnostic for melanoma.
Prescient Surgical is developing a single-use platform technology for the prevention of surgical site infection.
Relievant Medsystems is developing devices for the minimally invasive treatment of chronic low back pain.
ReThink Medical is developing a wearable medical device to monitor heart failure patients.
Reverse Medical develops devices focused on expanding the endovascular management of acute stroke, neuro and peripheral vascular disease. Covidien acquired Reverse Medical in August 2014.
Shape Memory Medical
Shape Memory Medical Inc. is developing novel peripheral vascular and neurovascular embolization devices based on an exciting new technology.
SinuSys is developing new therapies to improve the sinus health of patients.
Sonoma Orthopedics is developing devices which enable faster and less invasive fixation of bone fractures. Acquired by Arthrex July 2017.
SP Surgical was formed to develop a continuous suture passing device for minimally invasive orthopedic shoulder surgery.
Stimwave Technologies is leveraging patented advancements in nanotechnology to develop wireless devices for pain modulation.
Suture Ease develops unique facial closure system for laparoscopic procedures.
TransAortic Medical is developing accessory devices for use in trans-catheter aortic valve replacement procedures.
Twelve developed a transcatheter mitral valve replacement device and was acquired by Medtronic in August 2015.
VivaRay was formed to develop, manufacture and market devices for delivery of brachytherapy treatment in patients with gynecological cancer. Varian Medical Systems acquired VivaRay in March 2011.